Ph- Drugs for Movement Disorders Flashcards

1
Q

What drugs are used to increase dopamine bioavailability?

A
  1. levodopa

2. carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What drugs are used as dopamine receptor agonists?

A
  1. pramipexole

2. ropinirole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the monoamine oxidase B inhibitors?

A
  1. selegiline

2. rasagiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the catechol-O-methyl transferase [COMT] inhibitor?

A
  1. entacapone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the anticholinergic agents used in the treatment of movement disorders?

A
  1. benztropine

2. diphenhydramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What antiviral drug is also used to treat PD?

A
  1. amantadine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What drugs are used to treat spasticity?

A
  1. benzodiazopine [GABA agonist]
  2. baclofen
  3. dantrolene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

____________ is characterized by resting tremor, bradykinesia, rigidity.
_______________ is characterized by hyperkinetic symptoms, especially chorea.
_______________ is characterized by jerky, uncontrolled movements primarily of the face and limbs and is usually the result of use of antipsychotic medications.

A

Parkinson disease = resting tremor, bradykinesia, rigidity

Huntington’s disease = chorea, hyperkinesia

Dyskinesia [tardive dyskinesia] = jerky movements of the face and limbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the pyramidal and extrapyramidal systems for movement?

A

Pyramidal = UMN system that controls movement via primary motor cortex–> corticospinal tracts

Extrapyramidal = brainstem, thalamus, cortex, dentate gyrus of cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is considered to be the principle relay station of the basal ganglia? Why?

A

Striatum [caudate and putamen] is the principle relay center of the basal ganglia because it:

  1. receives input from the cerebral cortex and substantia nigra
  2. projects output to the 2 globus pallidus segments [external and internal] which transmit signal to the thalamus and back to the cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference in structure between D1 and D2 receptors? What does this mean for action?

A

D1 is Gs so it increases cAMP and releases more GABA to GPi.
GPi is inhibited so it cannot inhibit the thalamus.
The thalamus signals to the cortex –> movement.

D2 is Gi so it decreases cAMP and releases less Ach. This doesn’t activate the GABA inhibitor of GPe as much.
Increased GPe activity –> increased inhibition of STN.
Less STN stimulus –> less activation of SNr.
Less SNR –> less inhibition of the thalamus leading to increased movement .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The direct motor pathway which involves transmission of _____________ from a striatal neuron to the _________, will do what to the thalamus?
Activation of the indirect pathway, which involves transmission of __________ from a striatal neuron to the __________, will do what to the thalamus?

A

Direct:
Transmits GABA from striatum –> GPi which will disinhibit the thalamus

Indirect:
Transmission of GABA from striatum –> GPe which will increase the level of inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the effect of dopamine on the basal ganglia system?

A

DA activates the direct pathway [which disinhibits the thalamus] and inactivates the indirect pathway which normally inhibits the thalamus.

The net effect is decreased inhibition of the thalamus which leads to activation of cortical neurons that activate the spinal cord motor neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the pathophysiological effect of Parkinson disease on the extrapyramidal system?

A

Parkinson disease has a progressive loss of pars compacta in the substantia nigra. This leads to less dopamine.
Less dopamine will decrease the direct pathway and increase the effects of the indirect pathway leading to inhibition of the thalamus and decreased activation of cortical neurons for movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the effect of Huntington disease on the basal ganglia?

A

HD leads to degeneration of the GABA neurons of the indirect pathway.
This leads to decreased inhibition of GPe, which increases inhibition of the STN. There is less activation of SNr and less inhibition of the thalamus leading to excess stimulation of the thalamus .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is it possible for anticholinergics to help treat Parkinson disease?

A

Dopamine usually inhibits the release of Ach from D2 in the indirect pathway.

Ach activates the inhibitor of GPe which will reduce inhibition of STN which will increase activation of SNr and increase inhibition of the thalamus–> decreased movement.

Anticholinergics can be used to “turn off” the indirect pathway to release inhibition of the thalamus and increase movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the rate-limiting step of dopamine synthesis?

What cofactors are required for this step?

A

Tyrosine– [tyrosine hydroxylase]–> L-dopa

Cofactors necessary: tetrahydropterin, Fe2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What enzyme converts L-dopa to dopamine?

Where is the enzyme found?

A

aromatic amino acid decarboxylase {AAAD}

It is found in neuronal cytoplasm, but also has a broad tissue distribution in the periphery
*this explains why a lot of ingested L-Dopa is converted to dopamine in the periphery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dopamine is transported into synaptic vesicles by a transport protein that is inhibited by ___________.

A

Reserpine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe what happens when dopaminergic neurons are stimulated.

A
  1. intracellular free Ca rises and dopamine is released by exocytosis
  2. most of the released dopamine is taken back up by its selective transporter, DAT
  3. the dopamine that is not taken back up is metabolized by COMT, or is oxidized by MAO-B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Two enzymes in the periphery convert L-dopa to products that cannot cross the BBB.
In the treatment of parkinson’s, what drugs can be given with L-dopa to decrease this enzymatic activity, thus allowing more L-dopa to get into the CNS?

A
  1. L-dopa –AAAD—> dopamine
    * this is blocked by carbidopa
  2. L-dopa–COMT–> 3-O-methyldopa
    * this is blocked by tolcapone, entacapone
22
Q

Why is carbidopa able to block AAAD in the periphery, but still allows the conversion of L-dopa to dopamine in the brain?

A

It cannot cross the BBB

23
Q

What enzyme reduces dopamine in the neuron to DOPAC?

What drug can block this enzyme in order to increase the dopamine in the neurons?

A

MAO-B converts dopamine –>DOPAC

MAOIs like rotagiline and selegiline inhibit the conversion, thus increasing available dopamine

24
Q
The D1 class of receptors contains which 2 subtypes? 
What happens when DA binds?
The D2 class contains what 3 subtypes?
What happens when DA binds?
A

D1 = D1 and D5
When DA binds it activates adenyl cyclase –> increases cAMP

D2 = D2,3,4
When DA binds it inhibits adenylyl cyclase and reduces cAMP [open K channels, closed Ca]

25
Q

What is the most effective drug for the treatment of parkinson’s? Unfortunately, when does the therapeutic value begin to diminish?

A

Levodopa is the most effective drug, but its therapeutic value diminishes after 3 to 5 years

26
Q

Why is Levodopa given instead of dopamine itself?

A
  1. Dopamine cannot cross the BBB

2. dopamine causes nausea/vomiting

27
Q

What are the 2 negative consequences of L-dopa being converted to dopamine in the periphery?

A
  1. reduces bioavailability of L-dopa
  2. dopamine has adverse effects in the periphery such as:
    - nausea, vomiting
    - arrhythmia, orthostatic hypotension
28
Q

What factors alter the absorption time of L-dopa from the small intestine?

A
  1. gastric emptying time
  2. gastric pH
  3. the presence of other AAs from food that can compete with L-dopa transport
29
Q

What drug is given with levodopa to increase the bioavailability?
What ratio are the drugs usually given in?

A

carbidopa - peripheral decarboxylase {AAAD} inhibitor

Fixed prep 1:4 or 1:10 [Carbi:Levo]

30
Q

What are the adverse effects of levodopa?

A
  1. nausea/vomiting by stimulation of chemoreceptor trigger zone [CTZ]
  2. psychosis and hallucinations/schizophrenia [these are usually treated with dopamine blockers]
  3. dyskinesia- 5 to 8 years after treatment and dose dependent
  4. arrhythmia, orthostatic hypotension
  5. fluctuation in therapeutic response
  6. compulsive behavior
31
Q

What is the “buffering effect” seen in early stages of PD?

A

L-dopa affects all the symptoms of PD and the effects are prolonged beyond the metabolic half-life of the drug because the remaining functional neurons can store and release DA still.

Later in PD, this is loss and can explain fluctuations in the patients experience

32
Q

In late PD after buffering effect has worn off, what are the 2 major presentations of fluctuations?

A
  1. “end-dose deterioration”

2. “on-off phenomenon”

33
Q

What is “end-dose deterioration” for levodopa?

What are 2 ways to “fix” this? What is the major drawback to each approach?

A

Re-emergence of Parkinson symptoms 2-3 hours after taking the drug.
The effectiveness of the drug becomes shorter and shorter

  1. give higher dose –> can lead to dyskinesia
  2. give more frequent doses–> “on-off stages”
34
Q

What is the “on-off” phenomenon of PD?

A

Random, abrupt changes from normal state with reduced symptoms to Parkinson symptoms.

Time of switch is unexpected and independent of levodopa dose

35
Q

What are the 2 main reasons why levodopa is sometimes “reserved” for later into the course of parkinson’s?

A
  1. side effects like dyskinesia and psychosis are caused by cumulative L-dopa doses
  2. oxidative stress–> dopamine metabolism can increase toxic ROS
36
Q

What are the dopamine agonists?
What is the major benefit of using dopamine agonists over L-dopa?
What is the major drawback?

A

Pramipexole, ropinirole

Benefit:
1. do not require the presence of functional SN dopaminergic neurons for activity
2. less dyskinesia and motor fluctuations
Drawback:
1. higher incidence of psychosis
2. less effective at relieving motor symptoms

37
Q

What dopaminergic receptors do ropinirole and pramipexole bind?
What is the net effect?

A

They bind D3 with the highest affinity [but also D2, D4]

They DO NOT bind D1 or D5

Net effect is inhibition of the indirect pathway and increased stimulation of the thalamus

38
Q

What are the adverse effects of dopamine agonists [ropinirole, pramipexole]?

A
  1. nausea
  2. postural hypotension
  3. hallucinations, confusion, somnolence
  4. poor impulse control
39
Q

What anticholinergics are used in the treatment of PD?
What specific symptoms do they help improve?
What symptoms do they not really effect?
What are the adverse effects?

A
  1. diphenhydromine
  2. benztropine

They improve rigidity and pill rolling temor but do NOT help with bradykinesia.

The adverse effects are the same as any anti-histamine: drowsy, dry mouth, etc
In elderly: memory loss and dementia due to reduced cholinergic activity in the frontal lobes

40
Q

What are the 2 types of MAOs?

What does each preferentially metabolize?

A

MAO-A metabolizes 5-HT and NE

MAO-B is the main striatal form and is responsible for DA metabolism

41
Q

What are the two “suicide substrates” for MAO-B?

Why do they not induce the “cheese reaction” associated with general MAO blockers?

A

Selegiline and rasagiline are specific to MAO-B so they prolong DA .

The cheese reaction is due to tyramine buildup, but since MAO-A is still available, there is no adverse effect

42
Q

When are rasagiline and selegiline usually given in the course of PD?

A

They enhance L-dopa and decrease end-dose and on-off effect so they are usually reserved to be given with L-dopa after the response to L-dopa has begun to deteriorate.

They do NOT have therapeutic value alone .

43
Q

What drug should be avoided in a patient on MAOI?

A
  1. TCAI and SSRIs

2. analgesics [mepereidine]

44
Q

What are the 2 COMT inhibitors? What is the difference?

What is the major side effect of COMTI?

A

Tolcapone acts centrally and peripherally to block the conversion of L-dopa to 3-o-methyldopa

Entacapone acts only peripherally

Side effect: explosive diarrhea

45
Q

What antiviral can be used for Parkinson’s disease?What is the mechanism?

A

Amantidine is used but the mechanism is unclear

  1. enhance synthesis/release
  2. block reuptake after exocytosis
  3. antagonize NMDA receptors
46
Q

What is the inheritance pattern of HD?
What are the signs/symptoms?
What is the pathophysiology behind it?

A

It is AD and presents with:

  1. choreiform movement
  2. rigidity
  3. bradykinesia
  4. behavioral changes [aggression, depression]

it is caused by degeneration of GABA neurons in the striatum causing:

  1. reduced GABA
  2. reduced Ach
  3. normal or increased DA
47
Q

Spasticity is characterized by what?
What diseases would you commonly see it?
What is used to treat it?

A

It is characterized by:

  1. muscle weakness
  2. abnormal function of muscle

It is seen commonly with MS and cerebral palsy

Treated with muscle relaxants like:
baclofen, benzodiazepine, dantrolene

48
Q

What is the mechanism of action of baclofen?
What is it used to treat?
What are side effects?

A

It is a GABA-B receptor agonist which results in hyperpolarization of neurons due to increased K conductance.

It is used for ALS, MS, spinal cord injury

Side effects: weakness, drowsiness, lowered seizure threshold

49
Q

What is the mechanism of action of benzodiazepine?

What is it used to treat?

A

Facilitates action on GABA-A receptors to relieve acute muscle spasms

50
Q

What is the mechanism of action of dantrolene?

What is it used to treat?

A

It relaxes muscle by reducing Ca release from the SR.

It is used to treat malignant hyperthermia [triggered by anesthesia in central core muscles]

51
Q

What is the presentation of Tourettes?

What is the standard treatment?

A

It is characterized by multiple motor and vocal tics most likely caused by dopamine excess.
It is treated with haliparidol